Science Explorer Interactive view Map
Company · Pohang · South Korea

NovaCell Technology (South Korea)

Research works
22
▲ 207% vs 2013–17
Citations
1.5k
69.0 per fractional work
Top-10% rate
6.6%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: NovaCell Technology (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.32× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 9.08× its world share, 1 worksImmunology and Micro…Neuroscience: 7.38× its world share, 1 worksNeuroscienceChemistry: 2.06× its world share, 0 worksChemistryEngineering: 0.27× its world share, 0 worksEngineeringMedicine: 2.16× its world share, 4 worksMedicinePsychology: 0.18× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 9.1×. Every wedge is a field page.

Which keywords describe research at NovaCell Technology (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Cancer, Gene Therapy, CAR T Cells, Chimeric Antigen Receptor and Glycosylation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 9 words, with their numbers
  1. Immunotherapy2▲ 14×5 topics
  2. Tumor Regression2▲ 91×2 topics
  3. Cancer2▲ 5.3×14 topics
  4. Cancer Immunotherapy2▲ 46×2 topics
  5. Inflammation1▲ 2.7×10 topics
  6. CAR T Cells1▲ 120×1 topic
  7. Chimeric Antigen Receptor1▲ 120×1 topic
  8. Gene Therapy1▲ 20×4 topics
  9. Glycosylation1▲ 21×3 topics

Which research topics does NovaCell Technology (South Korea) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Research and Treatments, CRISPR and Genetic Engineering and Immune Cell Function and Interaction.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 CRISPR and Genetic Engineering Molecular Biology 0 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Synthesis and Biological Evaluation Organic Chemistry 0 works
  7. 7 Cell Image Analysis Techniques Biophysics 0 works
  8. 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  9. 9 Virus-based gene therapy research Genetics 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.5%not open54.5%

World: 28% of research is openly available.

with international co-authors20.2%domestic only79.8%

World: 19% is written across borders.

How has NovaCell Technology (South Korea)'s research output changed?

Output in 2018–2022 was 207% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Pohang

All research institutions in Pohang

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.